Related Experiment Video
Updated: Jun 29, 2025

Synthesis of Near-Infrared Emitting Gold Nanoclusters for Biological Applications
Published on: March 22, 2020
Theranostic and Combined Approaches Exploiting Multifunctional Gold Nanoclusters in Tumoral Ecosystems: A Paradigm
Shatrudhan Prajapati1, Shikha Yadav1, Javed Khan1
1Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.
Abstract:
Malignant tumors pose a significant threat to human life and well-being because of their rising occurrence and size. The current treatment methods and diagnostic techniques employed in clinical practice are inadequate for effectively treating tumors. Fluorescence, photothermal effects, radiosensitization, and biocompatibility are only a few instances of the unique photonic and physicochemical properties exhibited. Gold nanoclusters (AuNCs) are nanomaterials that possess modest dimensions, typically measuring approximately 3 nm, and are composed of a limited number of particles. AuNCs have three primary functions in practical applications: serving as imaging agents, drug transporters, and therapeutic agents. This article discusses nanosystems. The text emphasizes the promise of AuNCs for tumor theranostic and combination treatment while also acknowledging any existing limitations. Lastly, it is anticipated that the information presented here will serve as a valuable tool for researchers in this sector, resulting in novel perspectives and, ultimately, a wider adoption of AuNCs in pharmaceuticals. This study focuses on the expansion of diagnostic applications in cancer therapy by utilizing AuNC-based devices, made possible by the use of dynamic or passive tumor targeting techniques. The utilization of AuNCs has been thoroughly investigated for their prospective applicability as light-activated and radiation agents. Furthermore, they have been investigated as nanocarriers for transporting anticancer drugs. The medications can either bind to the closure receptor or be linked to the AuNCs through various techniques, showcasing their extensive potential for therapeutic applications.
Insights
Gold nanoclusters (AuNCs) show promise for advanced cancer diagnostics and therapies. These nanomaterials offer unique properties for imaging, drug delivery, and treatment, potentially improving outcomes for malignant tumors.
Area of Science:
- Nanotechnology
- Materials Science
- Biomedical Engineering
Background:
- Malignant tumors present a significant global health challenge.
- Current diagnostic and treatment modalities for tumors are often insufficient.
- Gold nanoclusters (AuNCs) are emerging nanomaterials with unique physicochemical properties.
Purpose of the Study:
- To explore the potential of gold nanoclusters (AuNCs) in cancer theranostics and combination therapies.
- To review the applications of AuNCs in diagnostics, drug delivery, and therapeutic treatments for tumors.
- To highlight the advantages and limitations of AuNCs in pharmaceutical applications.
Main Methods:
- Review of existing literature on gold nanoclusters (AuNCs) for cancer theranostics.
- Discussion of AuNCs' properties, including fluorescence, photothermal effects, and biocompatibility.
- Analysis of AuNC-based nanosystems for tumor targeting and therapeutic delivery.
Main Results:
- AuNCs demonstrate significant potential as imaging agents, drug transporters, and therapeutic agents.
- AuNCs can be utilized for light-activated and radiation-based cancer therapies.
- Various methods exist for attaching anticancer drugs to AuNCs for targeted delivery.
Conclusions:
- AuNCs offer a promising platform for advancing cancer diagnostics and combination therapies.
- Further research into AuNCs could lead to novel pharmaceutical applications and improved cancer treatment strategies.
- The development of AuNC-based devices, utilizing dynamic or passive tumor targeting, expands diagnostic capabilities in cancer therapy.
More Related Videos
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy